Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP).
Sturchio A, Marsili L, Vizcarra JA, Dwivedi AK, Kauffman MA, Duker AP, Lu P, Pauciulo MW, Wissel BD, Hill EJ, Stecher B, Keeling EG, Vagal AS, Wang L, Haslam DB, Robson MJ, Tanner CM, Hagey DW, El Andaloussi S, Ezzat K, Fleming RMT, Lu LJ, Little MA, Espay AJ. Sturchio A, et al. Among authors: hill ej. Front Aging Neurosci. 2020 Oct 8;12:553635. doi: 10.3389/fnagi.2020.553635. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33132895 Free PMC article.
High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis.
Sturchio A, Dwivedi AK, Young CB, Malm T, Marsili L, Sharma JS, Mahajan A, Hill EJ, Andaloussi SE, Poston KL, Manfredsson FP, Schneider LS, Ezzat K, Espay AJ. Sturchio A, et al. Among authors: hill ej. EClinicalMedicine. 2021 Jun 28;38:100988. doi: 10.1016/j.eclinm.2021.100988. eCollection 2021 Aug. EClinicalMedicine. 2021. PMID: 34505023 Free PMC article.
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.
Sturchio A, Dwivedi AK, Malm T, Wood MJA, Cilia R, Sharma JS, Hill EJ, Schneider LS, Graff-Radford NR, Mori H, Nübling G, El Andaloussi S, Svenningsson P, Ezzat K, Espay AJ; Dominantly Inherited Alzheimer Consortia (DIAN). Sturchio A, et al. Among authors: hill ej. J Alzheimers Dis. 2022;90(1):333-348. doi: 10.3233/JAD-220808. J Alzheimers Dis. 2022. PMID: 36120786 Free PMC article.
Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
Hill EJ, Mangleburg CG, Alfradique-Dunham I, Ripperger B, Stillwell A, Saade H, Rao S, Fagbongbe O, von Coelln R, Tarakad A, Hunter C, Dawe RJ, Jankovic J, Shulman LM, Buchman AS, Shulman JM. Hill EJ, et al. Parkinsonism Relat Disord. 2021 Mar;84:105-111. doi: 10.1016/j.parkreldis.2021.02.006. Epub 2021 Feb 10. Parkinsonism Relat Disord. 2021. PMID: 33607526 Free PMC article.
Genome Sequencing in the Parkinson Disease Clinic.
Hill EJ, Robak LA, Al-Ouran R, Deger J, Fong JC, Vandeventer PJ, Schulman E, Rao S, Saade H, Savitt JM, von Coelln R, Desai N, Doddapaneni H, Salvi S, Dugan-Perez S, Muzny DM, McGuire AL, Liu Z, Gibbs RA, Shaw C, Jankovic J, Shulman LM, Shulman JM. Hill EJ, et al. Neurol Genet. 2022 Jun 9;8(4):e200002. doi: 10.1212/NXG.0000000000200002. eCollection 2022 Aug. Neurol Genet. 2022. PMID: 35747619 Free PMC article.
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.
Pal G, Mangone G, Hill EJ, Ouyang B, Liu Y, Lythe V, Ehrlich D, Saunders-Pullman R, Shanker V, Bressman S, Alcalay RN, Garcia P, Marder KS, Aasly J, Mouradian MM, Link S, Rosenbaum M, Anderson S, Bernard B, Wilson R, Stebbins G, Nichols WC, Welter ML, Sani S, Afshari M, Verhagen L, de Bie RMA, Foltynie T, Hall D, Corvol JC, Goetz CG. Pal G, et al. Among authors: hill ej. Ann Neurol. 2022 Mar;91(3):424-435. doi: 10.1002/ana.26302. Epub 2022 Jan 25. Ann Neurol. 2022. PMID: 34984729 Free PMC article.
258 results